QuidelOrtho completes $3.4 billion debt refinancing

Go back to QuidelOrtho completes $3.4 billion debt refinancing

QuidelOrtho Completes Debt Refinancing

August 21, 2025 4:30 PM EDT

SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the completion of a series of related transactions to refinance its debt structure and support future growth. Through these transactions, the Company extended its debt maturities and reduced required amortization payments.

... More